Living Cell Technologies Ltd (LCT):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Living Cell Technologies Ltd (LCT) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10037
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:29
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ニュージーランド
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Living Cell Technologies Ltd (LCT) is a biotechnology company that develops cell-based therapeutics for the treatment of neurological diseases, diabetes, and stroke and hearing loss. It focuses on discovering regenerative treatments which restore function using naturally occurring cells. LCT develops its candidates based on its proprietary encapsulation technology, Immupel. Its lead product candidate, NTCELL is an alginate coated capsule containing clusters of neonatal porcine choroid plexus cells. It is in Phase IIb clinical trials for the treatment of Parkinson’s disease. The company is also developing the candidate in a number of other central nervous system indications, including Huntington’s, Alzheimer’s and motor neurone diseases including amyotrophic lateral sclerosis (ALS). LCT’s joint venture, Diatranz Otsuka Limited develops Diabecell, a cell therapy for type 1 diabetes. LCT is headquartered in Auckland, the New Zealand.

Living Cell Technologies Ltd (LCT) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Living Cell Technologies Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Living Cell Technologies Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Living Cell Technologies Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Living Cell Technologies Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Living Cell Technologies Ltd, Medical Devices Deals, 2012 to YTD 2018 9
Living Cell Technologies Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Living Cell Technologies Ltd, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Living Cell Technologies Enters into Research Agreement with The Centre for Brain Research 11
Licensing Agreements 12
Living Cell Technologies to Enter into Licensing Agreement with Diatranz Otsuka 12
Living Cell Technologies Enters into Licensing Agreement with Otsuka Pharma 13
Equity Offering 14
Living Cell Technologies to Raise Funds through Share Purchase Plan 14
Living Cell Technologies Raises USD2.8 Million in Private Placement of Shares 15
Acquisition 16
Otsuka Pharma to Acquire 50% Stake in Diatranz Otsuka from Living Cell Technologies for USD3 Million 16
Living Cell Technologies Ltd – Key Competitors 17
Living Cell Technologies Ltd – Key Employees 18
Living Cell Technologies Ltd – Locations And Subsidiaries 19
Head Office 19
Other Locations & Subsidiaries 19
Joint Venture 20
Recent Developments 21
Financial Announcements 21
Jul 26, 2018: Living Cell Technologies: Appendix 4C Quarterly Cash Flow Report 30 June 2018 21
Aug 23, 2017: Living Cell Technologies: Preliminary Final Report 30 June 2017 22
Jul 20, 2017: Living Cell Technologies: Appendix 4C Quarterly Cash Flow Report 30 June 2017 23
Corporate Communications 24
Aug 31, 2018: Living Cell Technologies: Roy Austin has stepped down from his role as Chairman and from his post 24
Other Significant Developments 25
Oct 29, 2018: Living Cell Technologies: Appendix 4c quarterly cash flow report 30 September 2018 25
Apr 11, 2018: LCT Strategy Update 26
Oct 18, 2017: Living Cell Technologies: Quarterly Cash Flow Report 30 September 2017 28
Appendix 29
Methodology 29
About GlobalData 29
Contact Us 29
Disclaimer 29

List of Tables
Living Cell Technologies Ltd, Pharmaceuticals & Healthcare, Key Facts, 2018 2
Living Cell Technologies Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Living Cell Technologies Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Living Cell Technologies Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Living Cell Technologies Ltd, Deals By Therapy Area, 2012 to YTD 2018 8
Living Cell Technologies Ltd, Medical Devices Deals, 2012 to YTD 2018 9
Living Cell Technologies Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Living Cell Technologies Enters into Research Agreement with The Centre for Brain Research 11
Living Cell Technologies to Enter into Licensing Agreement with Diatranz Otsuka 12
Living Cell Technologies Enters into Licensing Agreement with Otsuka Pharma 13
Living Cell Technologies to Raise Funds through Share Purchase Plan 14
Living Cell Technologies Raises USD2.8 Million in Private Placement of Shares 15
Otsuka Pharma to Acquire 50% Stake in Diatranz Otsuka from Living Cell Technologies for USD3 Million 16
Living Cell Technologies Ltd, Key Competitors 17
Living Cell Technologies Ltd, Key Employees 18
Living Cell Technologies Ltd, Subsidiaries 19
Living Cell Technologies Ltd, Joint Venture 20

List of Figures
Living Cell Technologies Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Living Cell Technologies Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Living Cell Technologies Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Living Cell Technologies Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Living Cell Technologies Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Living Cell Technologies Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Living Cell Technologies Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Living Cell Technologies Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Living Cell Technologies Ltd, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Living Cell Technologies Ltd (LCT):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Hochschild Mining plc:企業の戦略・SWOT・財務情報
    Hochschild Mining plc - Strategy, SWOT and Corporate Finance Report Summary Hochschild Mining plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Dynegy Inc.:戦略・SWOT・企業財務分析
    Dynegy Inc. - Strategy, SWOT and Corporate Finance Report Summary Dynegy Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Swissport Tanzania Limited:企業の戦略・SWOT・財務分析
    Swissport Tanzania Limited - Strategy, SWOT and Corporate Finance Report Summary Swissport Tanzania Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Eckert & Ziegler BEBIG SA (EZBG):企業の財務・戦略的SWOT分析
    Summary Eckert & Ziegler BEBIG SA (Eckert & Ziegler) a subsidiary of Eckert & Ziegler Strahlen- und Medizintechnik AG, is a medical device company that produces and distributes brachytherapy and radiotherapy products. The company offers products such as permanent prostate implants, HDR afterloaders, …
  • Faurecia S.A.:企業の戦略・SWOT・財務分析
    Faurecia S.A. - Strategy, SWOT and Corporate Finance Report Summary Faurecia S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Edion Corporation (2730):企業の財務・戦略的SWOT分析
    Edion Corporation (2730) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Delticom AG:企業の戦略・SWOT・財務情報
    Delticom AG - Strategy, SWOT and Corporate Finance Report Summary Delticom AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Eastern Company SAE:企業の戦略・SWOT・財務情報
    Eastern Company SAE - Strategy, SWOT and Corporate Finance Report Summary Eastern Company SAE - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Ora Gold Ltd (THX):企業の財務・戦略的SWOT分析
    Summary Ora Gold Ltd (Ora Gold) is a mining and mineral exploration company. The company acquires, explores and develops lead, zinc, silver, nickel, graphite, copper, gold and uranium prospects in Western Australia and the Northern Territory. Its projects include Red Bore Copper-Gold Project, Garden …
  • Baidu, Inc.:企業の戦略・SWOT・財務情報
    Baidu, Inc. - Strategy, SWOT and Corporate Finance Report Summary Baidu, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Ardian Holding SAS:企業の戦略的SWOT分析
    Ardian Holding SAS - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and ser …
  • Navidea Biopharmaceuticals Inc (NAVB)-製薬・医療分野:企業M&A・提携分析
    Summary Navidea Biopharmaceuticals Inc (Navidea) is a precision medicine company that focuses on the development and commercialization of radiopharmaceutical agents and precision diagnostics. Its key product, Lymphoseek (technetium Tc 99m tilmanocept) injection, is a radiopharmaceutical agent used i …
  • Bank Albilad:企業の戦略・SWOT・財務分析
    Bank Albilad - Strategy, SWOT and Corporate Finance Report Summary Bank Albilad - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • SL Green Realty Corp:企業のM&A・事業提携・投資動向
    SL Green Realty Corp - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's SL Green Realty Corp Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A …
  • Television Broadcasts Limited (511):企業の財務・戦略的SWOT分析
    Television Broadcasts Limited (511) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • FleetPride, Inc.:企業のM&A・事業提携・投資動向
    FleetPride, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's FleetPride, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), dives …
  • Hexion Inc.:戦略・SWOT・企業財務分析
    Hexion Inc. - Strategy, SWOT and Corporate Finance Report Summary Hexion Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Lukoil Oil Co (LKOH):企業の財務・戦略的SWOT分析
    Lukoil Oil Co (LKOH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • SeaWorld Entertainment, Inc.:企業の戦略・SWOT・財務情報
    SeaWorld Entertainment, Inc. - Strategy, SWOT and Corporate Finance Report Summary SeaWorld Entertainment, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • VertiFlex Inc:医療機器:M&Aディール及び事業提携情報
    Summary VertiFlex Inc (Vertiflex) is a medical device company that offers invasive treatments for lumbar stenosis. The company offers products such as interspinous spacer and direct decompression systems. Its interspinous spacer system is a motion-preserving, indirect decompression spinal implant sy …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆